Home › NDC Lookup › RxCUI directory › RxCUI 1941474

Nitisinone 2 MG Oral Tablet — RxCUI 1941474

RxNorm drug concept · Semantic clinical drug
RxCUI 1941474 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1941474
Official nameNitisinone 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)170 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nitisinone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nitisinone works by blocking a step in the breakdown of tyrosine — an amino acid found in many protein-rich foods. This means tyrosine can build up in your blood while you're on th...
  • Why do I have to follow a special diet while taking nitisinone?
  • High tyrosine levels can irritate and damage the surface of your eyes. Call your doctor right away if you notice eye pain, increased sensitivity to light, redness, swelling, or any...
  • What eye problems should I watch out for, and when should I call my doctor?
📖 Read our full Nitisinone guide →

🕸️ Concept Web — How Nitisinone 2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nitisinone 2 MG Oral Tablet RxCUI 1941474

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nitisinone 61805
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Harliku 2719717
    • Nityr 1941465
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nitisinone Oral Tablet 1941463
    • Nitisinone Oral Product 1158962
    • Nitisinone Pill 1158963
    • Nitisinone Oral Tablet [Harliku] 2719721
    • Nitisinone Oral Tablet [Nityr] 1941467
    • Harliku Oral Product 2719719
    • Harliku Pill 2719720
    • Nityr Oral Product 1941468
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nitisinone 2 MG SCDC · 353359
  • Nitisinone Oral Tablet SCDF · 1941463
  • Nitisinone Oral Product SCDG · 1158962
  • Nitisinone Pill SCDG · 1158963

Brand-Name Concepts

  • Nitisinone 2 MG Oral Tablet [Harliku] SBD · 2719722
  • Nitisinone 2 MG Oral Tablet [Nityr] SBD · 1941476
  • Nitisinone 2 MG [Harliku] SBDC · 2719718
  • Nitisinone 2 MG [Nityr] SBDC · 1941475
  • Nitisinone Oral Tablet [Harliku] SBDF · 2719721
  • Nitisinone Oral Tablet [Nityr] SBDF · 1941467
  • Harliku Oral Product SBDG · 2719719
  • Harliku Pill SBDG · 2719720
  • Nityr Oral Product SBDG · 1941468
  • Nityr Pill SBDG · 1941469

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1941474 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70709-0000-60 1 BOTTLE, PLASTIC in 1 CARTON (70709-000-60) / 60 TABLET in... NITYR Cycle Pharmaceuticals Ltd. 2017-07-26
70709-0002-60 1 BOTTLE, PLASTIC in 1 CARTON (70709-002-60) / 60 TABLET in... NITYR Cycle Pharmaceuticals Ltd. 2017-07-26
70709-0005-60 1 BOTTLE, PLASTIC in 1 CARTON (70709-005-60) / 60 TABLET in... NITYR Cycle Pharmaceuticals Ltd. 2017-07-26
70709-0112-60 1 BOTTLE, PLASTIC in 1 CARTON (70709-112-60) / 60 TABLET in... HARLIKU Cycle Pharmaceuticals Ltd. 2025-07-21
Observed labelers: Cycle Pharmaceuticals Ltd. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.